MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Cui, Yun ^a   Su, Wen Yu ^a   Xing, Jing ^a   Wang, Ying Chao ^a   Wang, Ping ^b   Chen, Xiao Yu ^a   Shen, Zhi Yong ^a   Cao, Hui ^a   Lu, You Yong ^c   Fang, Jing Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 29A; PROTEIN P42; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; MIRN29 MICRORNA, HUMAN; P42.3 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CARCINOGENICITY; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; P42 3 GENE; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; STOMACH CANCER; UPREGULATION; BIOLOGY; CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; AGED; BASE SEQUENCE; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 80053593567     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025872     Document Type: Article

References (34)

1. Golan A, Pick E, Tsvetkov L, Nadler Y, Kluger H, et al. (2010) Centrosomal Chk2 in DNA damage responses and cell cycle progession. Cell Cycle 13 [Epub ahead of print].
2. Gavet O, Pines J, (2010) Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev Cell 4: 533-543.
3. Xu X, Li W, Fan X, Liang Y, Zhao M, et al. (2007) Identification and characterization of a novel p42.3 gene as tumor-specific and mitosis phase-dependent expression in gastric cancer. Oncogene 52: 7371-7379.
4. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2: 281-297.
5. Lee Y, Jeon K, Lee JT, Kim S, Kim VN, (2002) MicroRNA maturation:stepwise processing and subcellurlar localization. EMBO J 17: 4663-4670.
6. Lee Y, Kim M, Han J, Yeom KH, Lee S, et al. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 20: 4051-4060.
7. Borchert GM, Lanier W, Davidson BL, (2006) RNA polymerase III transcribes human microRNAs. Nature Structural & Molecular Biology 12: 1097-1101.
8. Winter J, Jung S, Keller S, Gregory RI, Diederichs S, et al. (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 3: 228-234.
9. Thomas M, Lieberman J, Lal A, (2010) Desperately seeking microRNA targets. Nature Structural & Molecular Biology 10: 1169-1174.
10. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 2: 215-233.
11. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 1: 92-105.
12. Chawla G, Sokol NS, (2011) MicroRNAs in Drosophila Development. Int Rev Cell Mol Biol 286: 1-65.
13. Ohtani K, Dimmeler S, (2010) Control of cardiovascular differentiation by microRNAs. Basic Research in Cardiology 1: 5-11.
14. Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, et al. (2011) MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Molecular Cancer 10: 1.
15. Mutallip M, Nohata N, Hanazawa T, Kikkawa N, Horiguchi S, et al. (2010) Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133alpha in head and neck squamous cell carcinoma (HNSCC). Int J Mol Med 3: 345-352.
16. Chiang Y, Song Y, Wang Z, Chen Y, Yue Z, et al. (2011) Aberrant Expression of miR-203 and Its Clinical Significance in Gastric and Colorectal Cancers. J Gastrointest Surg 1: 63-70.
17. Persson H, Kvist A, Rego N, Staaf J, Vallon-Christersson J, et al. (2011) Identification of New MicroRNAs in Paired Normal and Tumor Breast Tissue Suggests a Dual Role for the ERBB2/Her2 Gene. Cancer Res 1: 78-86.
18. Muniyappa MK, Dowling P, Henry M, Meleady P, Doolan P, et al. (2009) MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. Eur J Cancer 17: 3104-3118.
19. Xu H, Cheung IY, Guo HF, Cheung NK, (2009) MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. Cancer Res 15: 6275-6281.
20. Santanam U, Zanesi N, Efanov A, Costinean S, Palamarchuk A, et al. (2010) Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc Natl Acad Sci U S A 27: 12210-12215.
21. Han YC, Park CY, Bhagat G, Zhang J, Wang Y, et al. (2010) microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med 3: 475-489.
22. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, et al. (2010) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 1: 209-218.
23. Kong L, Zhu J, Han W, Jiang X, Xu M, et al. (2010) Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol [Epub ahead of print].
24. Shioya M, Obayashi S, Tabunoki H, Arima K, Saito Y, et al. (2010) Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol Appl Neurobiol 4: 320-330.
25. Meng XZ, Zheng TS, Chen X, Wang JB, Zhang WH, et al. (2011) microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells. J Gastroenterol Hepatol 1: 186-193.
26. Pandey AK, Verma G, Vig S, Srivastava S, Srivastava AK, et al. (2011) miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells. Mol Cell Endocrinol 1-2: 125-133.
27. Huntzinger E, Izaurralde E, (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2: 99-110.
28. Zimmerman AL, Wu S, (2011) MicroRNAs, cancer and cancer stem cells. Cancer Lett 1: 10-19.
29. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 1: 91-105.
30. Megraw M, Sethupathy P, Corda B, Hatzigeorgiou AG, (2007) miRGen: a database for the study of animal microRNA genomic organization and function. Nucleic Acids Res Database issue pp. D149-155.
31. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res Database issue pp. D154-158.
32. Betel D, Koppal A, Agius P, Sander C, Leslie C, (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 8: R90.
33. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 4: 402-408.
34. Kruger, NJ, (1994) The Bradford method for protein quantitation. Methods Mol Biol 32: 9-15.